Frequency News and Research

RSS

Vitrase has been approved for use as an adjunct to rehydrating agents

The Food and Drug Administration approved Vitrase (hyaluronidase for injection). Vitrase is an injectable drug approved as an adjunct to (in combination with) other injected drugs to increase their absorption and dispersion. Hyaluronidase has been used most commonly in combination with local anesthetics in the setting of ophthalmic (eye) surgery.

6 May 2004

Experimental sleep drug eszopiclone helps elderly to sleep better

Older people with insomnia slept better and longer after taking an experimental sleep medication, according to research at Wake Forest University Baptist Medical Center.

6 May 2004

Female testosterone patch significantly increased satisfying sexual activity and desire

Data from a landmark Phase III safety and efficacy study of 562 women showed treatment with an investigational female testosterone patch significantly increased satisfying sexual activity and desire in patients with Hypoactive Sexual Desire Disorder (HSDD), who previously had both ovaries removed. HSDD is defined as a lack of sexual desire that causes a woman personal distress.

6 May 2004

New estimate of more than three million diabetes-related deaths every year

3.2 million deaths can be attributed to diabetes each year according to a new publication released today by the World Health Organization (WHO) and the International Diabetes Federation (IDF) to mark the launch of their joint programme "Diabetes Action Now".

5 May 2004

IT has the power to transform the pharmaceutical industry

Information technology has the power to transform the pharmaceutical industry, if businesses apply it correctly. That’s the conclusion of Pharma 2010: Silicon Reality, a report from IBM Business Consulting Services (BCS).

5 May 2004

New estimate of more than three million diabetes-related deaths every year

5 May 2004

First drug product for treatment of short bowel syndrome

Short bowel syndrome (SBS) is a rare and potentially life-threatening condition in which the ability of the small intestine to absorb the nutrition a person needs from food is impaired. Short bowel syndrome can occur after surgical removal of part of the intestine, due to trauma or because the intestine is diseased.

4 May 2004

Eating habits matter as much as medicine for those with type 2 diabetes

For those with type 2 diabetes, the most prevalent kind, a person's eating habits -- their basic eating practices, selections while dining out, meal planning and carbohydrate and vegetable strategies -- matter as much or more as medicine for maintaining blood sugar control, says a Penn State researcher.

3 May 2004

Study suggest that decriminalization of marijuana does not lead to increased drug use

In the first rigorous study comparing marijuana use in the Netherlands and the United States, researchers have found no evidence that decriminalization of marijuana leads to increased drug use. The results suggest that drug policies may have less impact on marijuana use than is currently thought.

3 May 2004

New electromagnetic imaging techniques to help detect breast abnormalities

Researchers are testing three promising new electromagnetic imaging techniques to help detect breast abnormalities, including cancer. The findings of the benchmark study will be published in the May issue of the journal Radiology.

3 May 2004

Rates of hepatitis A higher in an El Niño year

Researchers at the Queensland University of Technology have examined the possible association between the Southern Oscillation Index and the occurrence of hepatitis A in Australia. The results indicate that the SOI is statistically significantly associated with the transmission of hepatitis A.

2 May 2004

Scientists find genetic link between prostate cancer and hereditary form of breast and ovarian cancer

A new study shows that the risk for prostate cancer is significantly elevated in men who are part of families with a hereditary form of breast and ovarian cancer. Researchers at Memorial Sloan-Kettering Cancer Center have determined that men in families carrying BRCA genetic mutations have a three- to five-fold increased risk of prostate cancer.

1 May 2004

Warning to parents-to-be that non-medical ultrasounds are unapproved, inappropriate, and possibly even risky

For many expectant parents, ultrasounds offer a window into the world of their growing unborn baby. Unlike most standard prenatal tests that involve nothing more than a urine cup or a needle

1 May 2004

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.

30 Apr 2004

New technique of identifying genes may help researchers developing drugs

A quick new technique able to identify genes that evolve rapidly as well as those that change slowly already has pinpointed new targets for researchers developing drugs against tuberculosis and malaria, and it could do the same for other infectious diseases, according to a paper in this week's Nature.

29 Apr 2004

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Two studies presented today at the American Academy of Neurology (AAN) 56th Annual Meeting show that pregabalin, when used as an add-on treatment for epilepsy, does not affect male reproductive function or interfere with the effectiveness of oral contraceptives.

29 Apr 2004

Australian research finds wine reduces ovarian cancer risk

In Queensland, Australia cancer researchers have given new hope to women who enjoy the occasional glass of wine. Their study showed the risk of developing ovarian cancer was dramatically reduced in women who drank at least one standard glass of wine a day.

28 Apr 2004

Serono says Rebif an effective treatment for brain lesions

New long-term data support the importance of early treatment with high dose, high frequency Rebif® (interferon beta-1a) 44 mcg in reducing the long-term accumulation of brain lesion volume in patients with relapsing remitting multiple sclerosis (MS).

28 Apr 2004

Antiepileptic drug levetiracetam (Keppra) shown to help chronic daily headaches

The antiepileptic drug levetiracetam (Keppra(R)) significantly reduced the frequency and impact of headaches in patients diagnosed with transformed migraine, according to a new study presented today at the 56th annual meeting of the American Academy of Neurology (AAN).

27 Apr 2004

A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States

A high rate of marriage among deaf individuals can explain the increased frequency of connexin deafness in the United States and may have led to a doubling of its occurrence during the past 200 years, according to a study by hereditary deafness experts at Virginia Commonwealth University.

27 Apr 2004